A biology-based quality-diversity algorithm for drug repurposing in Alzheimer's disease using automated machine learning.

The statistical analysis confirmed that the retrieval variability in the full-feature XGBoost baseline is significantly higher than the highly stable performance of MAP-Elites in the primary setting (Recall SD \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\pm$$\end{document} 0.017), yielding a highly significant difference in stability ( \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$p < 0.01$$\end{document} , F-test).

also in 132,142 other papers